Abeona Therapeutics (ABEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 23,695 | 14,811 | 14,555 | 38,829 | 12,596 |
| Marketable Securities | 74,363 | 37,753 | 37,932 | 12,086 | 82,438 |
| Receivables | 1,652 | 2,444 | 188 | 3,000 | N/A |
| TOTAL | $100,853 | $55,737 | $53,099 | $56,292 | $97,742 |
| Non-Current Assets | |||||
| PPE Net | 4,430 | 3,533 | 5,741 | 12,339 | 11,322 |
| Intangibles | 0 | 0 | 0 | 1,384 | 33,966 |
| Other Non-Current Assets | 3,648 | 4,732 | 5,374 | 9,571 | 8,168 |
| TOTAL | $8,078 | $8,265 | $11,115 | $23,294 | $53,456 |
| Total Assets | $108,931 | $64,002 | $64,214 | $79,586 | $151,198 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 5,926 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 3,441 | 6,438 | 1,811 | 8,924 | 36,210 |
| Accrued Expenses | 6,333 | 5,985 | 3,991 | 5,585 | 3,410 |
| Other current liabilities | 64 | 1 | 204 | 296 | N/A |
| TOTAL | $16,587 | $13,422 | $7,779 | $16,623 | $41,959 |
| Non-Current Liabilities | |||||
| Long Term Debt | 13,037 | N/A | N/A | N/A | 1,428 |
| Deferred Revenues | N/A | N/A | N/A | N/A | 296 |
| Other Non-Current Liabilities | 35,276 | 35,754 | 29,674 | 20,595 | 5,260 |
| TOTAL | $48,313 | $35,754 | $29,674 | $20,595 | $6,688 |
| Total Liabilities | $64,900 | $49,176 | $37,453 | $37,218 | $48,647 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 48,534 | 27,355 | 17,709 | 5,895 | 3,952 |
| Common Shares | 457 | 265 | 177 | 1,472 | 961 |
| Retained earnings | -813,258 | -749,524 | -695,336 | -655,640 | -570,704 |
| Other shareholders' equity | 8 | -66 | -129 | -27 | -10 |
| TOTAL | $44,031 | $14,826 | $26,761 | $42,368 | $102,551 |
| Total Liabilities And Equity | $108,931 | $64,002 | $64,214 | $79,586 | $151,198 |